Cargando…

Response to the editorial “COVID-19 in patients with cardiovascular diseases”: Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes

Detalles Bibliográficos
Autores principales:	Funck-Brentano, Christian, Salem, Joe-Elie, Nguyen, Lee S., Drici, Milou-Daniel, Roden, Dan M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Masson SAS. 2020
Materias:	Letters to the Editors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158843/ https://www.ncbi.nlm.nih.gov/pubmed/32331979 http://dx.doi.org/10.1016/j.acvd.2020.04.001

Ejemplares similares

RETRACTED: Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous?
por: Funck-Brentano, Christian, et al.
Publicado: (2020)

Cardiovascular Toxicities Associated With Hydroxychloroquine and Azithromycin: An Analysis of the World Health Organization Pharmacovigilance Database
por: Nguyen, Lee S., et al.
Publicado: (2020)

Retraction and republication: cardiac toxicity of hydroxychloroquine in COVID-19
por: Funck-Brentano, Christian, et al.
Publicado: (2020)

Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine
por: Sarayani, Amir, et al.
Publicado: (2021)

QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin
por: Chorin, Ehud, et al.
Publicado: (2020)

“Off-label” use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers
por: Gérard, Alexandre, et al.
Publicado: (2020)

Torsade de pointes associated with chloroquine, hydroxychloroquine, and azithromycin: a retrospective analysis of individual case safety reports from VigiBase
por: Saint-Gerons, Diego Macías, et al.
Publicado: (2021)

Hydroxychloroquine/chloroquine and azithromycin in COVID-19 patients: prospective study of electrical parameters
por: Ammor, Othmane, et al.
Publicado: (2021)

Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine
por: Bakadia, Bianza Moise, et al.
Publicado: (2021)

Azithromycin/hydroxychloroquine: Torsade-de-pointes following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Torsades-de-pointes following off label treatment: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Torsades de pointes following off-label use: case report
Publicado: (2021)

Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence
por: Roustit, M., et al.
Publicado: (2020)

Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
Publicado: (2022)

QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review
por: Jankelson, Lior, et al.
Publicado: (2020)

Summary of adverse drug events for hydroxychloroquine, azithromycin, and chloroquine during the COVID-19 pandemic
por: Dauner, Daniel G., et al.
Publicado: (2021)

Chloroquine, hydroxychloroquine and COVID-19
por: Erickson, T. B., et al.
Publicado: (2020)

COVID-19 Drugs Chloroquine and Hydroxychloroquine, but Not Azithromycin and Remdesivir, Block hERG Potassium Channels
por: Szendrey, Mark, et al.
Publicado: (2021)

Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-19
por: Zahr, Noël, et al.
Publicado: (2021)

Chloroquine and hydroxychloroquine in the context of COVID-19
por: Shukla, Ashutosh M, et al.
Publicado: (2020)

Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
por: Principi, Nicola, et al.
Publicado: (2020)

QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin
por: Hsia, Brian C, et al.
Publicado: (2020)

A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment
por: Ghazy, Ramy Mohamed, et al.
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc interval prolongation and torsades de pointes following off-label use: case report
Publicado: (2020)

QTc Prolongation Risk Evaluation in Female COVID-19 Patients Undergoing Chloroquine and Hydroxychloroquine With/Without Azithromycin Treatment
por: Grewal, Sarah, et al.
Publicado: (2020)

PIN3 Chloroquine and Hydroxychloroquine in COVID-19 with or without Azithromycin: A Systematic Review of in Vitro and Clinical Studies
por: Jameleddine, M., et al.
Publicado: (2020)

Torsade de pointes caused by hydroxychloroquine use in a patient with a severe form of COVID-19
por: Zarrouki, Y, et al.
Publicado: (2020)

Risks of chloroquine or hydroxychloroquine use for COVID-19
Publicado: (2020)

COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?
por: Marmor, Michael F.
Publicado: (2020)

COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?
por: Marmor, Michael F.
Publicado: (2020)

Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic()
por: Jáuregui, Edwin
Publicado: (2021)

Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
por: Mahmoudi, Javad, et al.
Publicado: (2021)

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
por: Ho, Tzu-Chuan, et al.
Publicado: (2021)

Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19
por: Singh, Bhagteshwar, et al.
Publicado: (2021)

Evidence for Chloroquine/Hydroxychloroquine in the Treatment of COVID-19
por: Shetty, Rajesh M, et al.
Publicado: (2021)

Hydroxychloroquine-azithromycin for COVID-19 – Warranted or dangerous?
por: Popescu, Corneliu P., et al.
Publicado: (2020)

Hydroxychloroquine and azithromycin as a treatment of COVID-19
por: Fanin, Alice, et al.
Publicado: (2020)

Cardiovascular Safety of Hydroxychloroquine–Azithromycin in 424 COVID-19 Patients
por: Million, Matthieu, et al.
Publicado: (2023)

An Umbrella Review of Clinical Efficacy and Adverse Cardiac Events Associated with Hydroxychloroquine or Chloroquine with or Without Azithromycin in Patients with COVID-19
por: Shahsavarinia, Kavous, et al.
Publicado: (2021)

Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study
por: Rouamba, Toussaint, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_inl394s27s3ercsakakv1gsbf0